Anal cancer treated with intensity modulated radiation therapy (IMRT) and concurrent chemotherapy: A dosimetric analysis of acute gastrointestinal toxicity

被引：1
|
作者：
Devisetty, K.
Mell, L. K.
Salama, J. K.
Jani, A. B.
Mundt, A. J.
Roeske, J.
Aydogan, B.
Chmura, S. J.
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Illinois, Chicago, IL USA
[3] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.542
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2138
引用
收藏
页码：S287 / S288
页数：2
相关论文
共 50 条
  • [1] Dosimetric predictors of acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity modulated radiation therapy (IMRT)
    Mell, L. K.
    Salama, J. K.
    Roeske, J. C.
    Devisetty, K.
    Jani, A. B.
    Mundt, A. J.
    Chmura, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S277 - S278
  • [2] A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy
    Devisetty, Kiran
    Mell, Loren K.
    Salama, Joseph K.
    Schomas, David A.
    Miller, Robert C.
    Jani, Ashesh B.
    Roeske, John C.
    Aydogan, Bulent
    Chmura, Steven J.
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (02) : 298 - 301
  • [3] Dosimetric Parameters Are Predictive of Acute Gastrointestinal Toxicity in Patients Treated with Concurrent Chemotherapy and Intensity Modulated Radiation Therapy for Anal Carcinoma
    DeFoe, S. G.
    Kehwar, T. S.
    Beriwal, S.
    Won, S.
    Jones, H. A.
    Heron, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S69 - S69
  • [4] Dosimetric Parameters Predictive of Acute Gastrointestinal Toxicity in Patients with Anal Carcinoma Treated with Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy
    DeFoe, S. Gillianne
    Kabolizadeh, Peyman
    Heron, Dwight E.
    Beriwal, Sushil
    ONCOLOGY, 2013, 85 (01) : 1 - 7
  • [5] Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Anal Cancer Outcomes and Toxicity
    Mitchell, Melissa P.
    Abboud, Mirna
    Eng, Cathy
    Beddar, A. Sam
    Krishnan, Sunil
    Delclos, Marc E.
    Crane, Christopher H.
    Das, Prajnan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (05): : 461 - 466
  • [6] Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancers: Acute toxicity profile and avoidance of a treatment break
    Nordal, R. A.
    Wood, T. E.
    Posey, J. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Analysis of acute toxicity for patients with breast cancer treated with intensity modulated radiation therapy (IMRT)
    Deutsch, M
    Bhatnagar, AK
    Heron, DE
    Shogan, JE
    Lalonde, R
    Huq, MS
    Sontag, M
    Ross, G
    Andrade, RS
    Beriwal, S
    Quinn, AE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S184 - S185
  • [8] INTENSITY MODULATED RADIOTHERAPY (IMRT) AND CONCURRENT CHEMOTHERAPY (CHT) FOR ANAL AND PERIANAL CANCER: PRELIMINARY REPORT OF ACUTE TOXICITY
    Han, K.
    Cummings, B. J.
    Bayley, A. J.
    Brierley, J. D.
    Dawson, L.
    Dinniwell, R.
    Ringash, J.
    Wong, R. K.
    Krzyzanowska, M. K.
    MacKay, H. J.
    Moore, M. J.
    Chen, E. X.
    Craig, T.
    Kim, J. J.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S58 - S58
  • [9] Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer
    Franco, P.
    Ragona, R.
    Arcadipane, F.
    Mistrangelo, M.
    Cassoni, P.
    Rondi, N.
    Morino, M.
    Racca, P.
    Ricardi, U.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 67 - 75
  • [10] Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer
    P. Franco
    R. Ragona
    F. Arcadipane
    M. Mistrangelo
    P. Cassoni
    N. Rondi
    M. Morino
    P. Racca
    U. Ricardi
    Clinical and Translational Oncology, 2017, 19 : 67 - 75
12345